Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of APDS in the European Union
GlobeNewswire
*L**eiden**, **the **Netherlands, May 30, 2024**:* Pharming Group N.V. (“Pharming” or “the Company”) (EURONEXT Amsterdam:..